Succinylcholine-induced hyperkalemia in a patient with mucositis secondary to chemotherapy

Critical Care Medicine

Volumn 29, Issue 6, 2001, Pages 1274-1276

  Al Khafaji, Ali H ^a   Dewhirst, William E ^a   Cornell Jr , Cornelius J ^a   Quill, Timothy J ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

Chemotherapy; Hyperkalemia; Mucositis; Succinylcholine

Indexed keywords

BICARBONATE; CYTARABINE; DAUNORUBICIN; ETOMIDATE; METHOTREXATE; POTASSIUM; SUXAMETHONIUM;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CANCER CHEMOTHERAPY; CASE REPORT; DRUG CONTRAINDICATION; DYSPNEA; FATALITY; FEMALE; HEART ARREST; HUMAN; HYPERKALEMIA; INTENSIVE CARE; INTUBATION; MENTAL HEALTH; MUCOSA INFLAMMATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; THERMAL INJURY;

EID: 0034987740     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200106000-00040     Document Type: Article

References (13)

1. Suxamethonium and hyperkalemia
2. Changes in plasma potassium concentration after depolarizing blockers in anaesthetized man
3. Hyperkalemia and cardiovascular collapse following administration of succinylcholine to the traumatized patient
4. Pathophysiology of hyperkalemia induced by succinylcholine
5. Succinylcholine induced hyperkalemia following prolonged pharmacologic neuromuscular blockade
6. Succinylcholine induces hyperkalemia in critically ill patients
7. Hyperkalemic cardiac arrest following succinylcholine in a long-term intensive care patient
8. Oral complication in patients receiving treatment for malignancies other than the head and neck
9. Consensus development conference on oral complication of cancer therapies: Diagnosis, prevention and treatment
10. Reducing the incidence of stomatitis using a quality assessment and improvement approach
11. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy
12. Changes in acetylcholine receptor number in muscle from critically ill patients receiving muscle relaxants: An investigation of the molecular mechanism of prolonged paralysis
13. Chemotherapy of intermediate- and high-grade non-Hodgkin's lymphomas with an intensive epirubicin-containing regimen